{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T21:23:26Z","timestamp":1787261006555,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ctro.2026.101188","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:31:19Z","timestamp":1779676279000},"page":"101188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Wide dural radiation therapy for NF2-SWN associated meningiomatosis"],"prefix":"10.1016","volume":"60","author":[{"given":"Jaiwo","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Woo","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Yeon","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyoung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hee","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong In","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101188_b0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor prone syndromes: estimates from a UK genetic family register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am J Med Genet."},{"key":"10.1016\/j.ctro.2026.101188_b0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00129492-200501000-00016","article-title":"Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought","volume":"26","author":"Evans","year":"2005","journal-title":"Otol Neurotol."},{"key":"10.1016\/j.ctro.2026.101188_b0015","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0140-6736(09)60259-2","article-title":"Neurofibromatosis type 2","volume":"373","author":"Asthagiri","year":"2009","journal-title":"Lancet."},{"key":"10.1016\/j.ctro.2026.101188_b0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-4-16","article-title":"Neurofibromatosis type 2 (NF2): A clinical and molecular review","volume":"4","author":"Evans","year":"2009","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.ctro.2026.101188_b0025","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/oxfordjournals.qjmed.a068699","article-title":"A clinical study of type 2 neurofibromatosis","volume":"84","author":"Evans","year":"1992","journal-title":"Q J Med"},{"key":"10.1016\/j.ctro.2026.101188_b0030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11060-010-0339-x","article-title":"Meningiomas and neurofibromatosis","volume":"99","author":"Goutagny","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ctro.2026.101188_b0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ajmg.1320520411","article-title":"Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity","volume":"52","author":"Parry","year":"1994","journal-title":"Am J Med Genet."},{"issue":"1","key":"10.1016\/j.ctro.2026.101188_b0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ajmg.a.34359","article-title":"Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2","volume":"158","author":"Blakeley","year":"2012","journal-title":"American journal of medical genetics Part A"},{"issue":"1","key":"10.1016\/j.ctro.2026.101188_b0045","first-page":"99","article-title":"The genetic landscape and possible therapeutics of neurofibromatosis type 2. Cancer cell","volume":"23","author":"Ghalavand","year":"2023","journal-title":"international"},{"issue":"1","key":"10.1016\/j.ctro.2026.101188_b0050","first-page":"vdad041","article-title":"Prospective phase II trial of the dual mTORC1\/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2","volume":"5","author":"Jordan","year":"2023","journal-title":"Neurooncol Adv"},{"issue":"1","key":"10.1016\/j.ctro.2026.101188_b0055","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijrobp.2008.03.073","article-title":"Clinical experience with radiation therapy in the management of neurofibromatosis-associated central nervous system tumors","volume":"73","author":"Wentworth","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"10.1016\/j.ctro.2026.101188_b0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3171\/2020.12.JNS202814","article-title":"Neurofibromatosis type 2-associated meningiomas: an international multicenter study of outcomes after Gamma Knife stereotactic radiosurgery","volume":"136","author":"Mohammed","year":"2022","journal-title":"J Neurosurg."},{"issue":"9","key":"10.1016\/j.ctro.2026.101188_b0065","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.gim.2022.05.007","article-title":"Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: A consensus recommendation","volume":"24","author":"Plotkin","year":"2022","journal-title":"Genetics in Medicine."},{"issue":"4","key":"10.1016\/j.ctro.2026.101188_b0070","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3171\/2024.7.JNS231815","article-title":"Primary and salvage radiosurgery for neurofibromatosis type 2-associated meningiomas","volume":"142","author":"Wei","year":"2024","journal-title":"J Neurosurg."},{"key":"10.1016\/j.ctro.2026.101188_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.908745","article-title":"Radiation of meningioma dural tail may not improve tumor control rates","author":"Piper","year":"2022","journal-title":"Front Surg."},{"issue":"10","key":"10.1016\/j.ctro.2026.101188_b0080","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/jnen\/60.10.994","article-title":"Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases","volume":"60","author":"Perry","year":"2001","journal-title":"J Neuropathol Exp Neurol."},{"issue":"4","key":"10.1016\/j.ctro.2026.101188_b0085","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1468-2982.2009.01970.x","article-title":"Headache attributed to intracranial tumours: a prospective cohort study","volume":"30","author":"Valentinis","year":"2010","journal-title":"Cephalalgia."},{"issue":"5","key":"10.1016\/j.ctro.2026.101188_b0090","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/neuonc\/nou025","article-title":"Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review","volume":"16","author":"Kaur","year":"2014","journal-title":"Neuro Oncol."},{"issue":"3","key":"10.1016\/j.ctro.2026.101188_b0095","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ijrobp.2023.09.026","article-title":"Dose-escalated radiation therapy is associated with improved outcomes for high-grade meningioma","volume":"118","author":"Zeng","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"10.1016\/j.ctro.2026.101188_b0100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2018.05.001","article-title":"Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus","volume":"128","author":"Lambrecht","year":"2018","journal-title":"Radiotherapy and Oncology."},{"issue":"4","key":"10.1016\/j.ctro.2026.101188_b0105","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3171\/jns.1991.75.4.0564","article-title":"Radiation-induced meningiomas: experience at the Mount Sinai Hospital and review of the literature","volume":"75","author":"Harrison","year":"1991","journal-title":"Journal of Neurosurgery."},{"issue":"4","key":"10.1016\/j.ctro.2026.101188_b0110","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1054\/bjoc.1999.1030","article-title":"Neurofibromatosis 2, radiosurgery and malignant nervous system tumours","volume":"82","author":"Baser","year":"2000","journal-title":"British Journal of Cancer."},{"issue":"9","key":"10.1016\/j.ctro.2026.101188_b0115","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S1474-4422(09)70204-2","article-title":"Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up","volume":"8","author":"Douw","year":"2009","journal-title":"Lancet Neurology."},{"issue":"34","key":"10.1016\/j.ctro.2026.101188_b0120","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1200\/JCO.2014.57.2909","article-title":"Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933)","volume":"32","author":"Gondi","year":"2014","journal-title":"Journal of Clinical Oncology."},{"issue":"4","key":"10.1016\/j.ctro.2026.101188_b0125","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.ijrobp.2010.01.039","article-title":"Hippocampal-sparing whole-brain radiotherapy: a \u201chow-to\u201d technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy","volume":"78","author":"Gondi","year":"2010","journal-title":"International Journal of Radiation Oncology Biology Physics."},{"issue":"6","key":"10.1016\/j.ctro.2026.101188_b0130","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jmg.35.6.450","article-title":"Genotype\/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations","volume":"35","author":"Evans","year":"1998","journal-title":"Journal of Medical Genetics."}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:24:13Z","timestamp":1787257453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826000832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":26,"alternative-id":["S2405630826000832"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101188","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Wide dural radiation therapy for NF2-SWN associated meningiomatosis","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101188","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101188"}}